Indian CRDMOs Gain As Global Pharma Diversifies: Jefferies
The Business Guardian
|June 28, 2025
Indian CRDMOs (Contract Research and Development and Manufacturing Organizations) are seeing growing interest from global pharmaceutical companies, according to a recent report by Jefferies.
The report highlighted that Big Pharma companies are increasingly diversifying their manufacturing and research operations geographically, and Indian companies with expertise in small molecule development are well placed to benefit.
It said "Big Pharma is diversifying geographically, benefiting Indian CRDMOs with small molecule expertise."
The report highlighted some major pharma companies (including Piramal Pharma, Syngene, Laurus Labs, Cohance, Gland Pharma).
The report said that these companies highlighted that many of the ongoing projects are still in the clinical stages, so growth may be uneven.
There is also a rising demand for antibody-drug conjugate (ADC)-related CDMO services, and Indian companies are exploring opportunities in that space.
Cette histoire est tirée de l'édition June 28, 2025 de The Business Guardian.
Abonnez-vous à Magzter GOLD pour accéder à des milliers d'histoires premium sélectionnées et à plus de 9 000 magazines et journaux.
Déjà abonné ? Se connecter
PLUS D'HISTOIRES DE The Business Guardian
The Business Guardian
India's CBG capacity reaches 920 TPD with 132 plants: Hardeep Puri
India has established 132 Compressed Bio Gas (CBG) plants with a total production capacity of 920 tonnes per day (TPD) as part of its ongoing efforts to enhance renewable energy infrastructure, said Union Minister for Petroleum and Natural Gas, Hardeep Singh Puri on X.
2 mins
January 04, 2026
The Business Guardian
Transport Ministry proposes Aadhaar-like numbers for EV batteries
The transport ministry has proposed assigning Aadhaar-like unique identification number to EV batteries to ensure their end-to-end traceability and efficient recycling.
2 mins
January 04, 2026
The Business Guardian
BANK CREDIT TO INDUSTRY RISES 9.6% IN NOV
Bank credit to industry grew at a faster pace of 9.6 per cent in November 2025 as against 8.3 per cent in the same month of the preceding year, according to Reserve Bank data.
1 mins
January 04, 2026
The Business Guardian
INDIA'S FOREX RESERVES JUMP BY USD 3.293 BLN
India's forex reserves jumped by USD 3.293 billion to USD 696.61 billion in the week to December 26, the RBI said on Friday.
2 mins
January 04, 2026
The Business Guardian
KERALA GOVERNMENT GRANTS RS 93.72 CRORE AID TO KSRTC
The Kerala government has sanctioned an additional Rs 93.72 crore as financial assistance to the KSRTC, state Finance Minister K N Balagopal said on Saturday.
1 min
January 04, 2026
The Business Guardian
From fragmented higher education regulator to Viksit Bharat command
The Viksit Bharat Shiksha Adhishthan Bill 2025, introduced in Parliament on 15th December, responds to a longstanding need in our higher education system.
5 mins
January 04, 2026
The Business Guardian
Elliott partner Jason Genrich has left hedge fund
Elliott Investment Management on Friday told clients that Jason Genrich, who led many of the firm's technology investments, has left the hedge fund, according to two people familiar with the matter.
1 min
January 04, 2026
The Business Guardian
TRUMP BLOCKS CHIPS DEAL, CITES SECURITY, CHINA-RELATED CONCERNS
President Donald Trump on Friday blocked U.S. photonics firm HieFo Corp's $3 million acquisition of assets in New Jersey-based aerospace and defense specialist Emcore, citing national security and China-related concerns.
1 min
January 04, 2026
The Business Guardian
Health subsidies expire, launching millions of Americans into 2026
Enhanced tax credits that have helped reduce the cost of health insurance for the vast majority of Affordable Care Act enrollees expired overnight, cementing higher health costs for millions of Americans at the start of the new year.
2 mins
January 04, 2026
The Business Guardian
TESLA LOSES TITLE AS BIGGEST EV MAKER
Tesla lost its crown as the world’s bestselling electric vehicle maker on Friday as a customer revolt over Elon Musk’s right-wing politics, expiring US. tax breaks for buyers and stiff overseas competition pushed sales down for a second year in a row.
1 mins
January 04, 2026
Listen
Translate
Change font size